cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Sulistyawati, S.Si., MPH, Ph.D
Contact Email
sulistyawati.suyanto@ikm.uad.ac.id
Phone
+628170402693
Journal Mail Official
sulistyawati.suyanto@ikm.uad.ac.id
Editorial Address
Jalan Prof Dr. Soepomo, Janturan, Umbulharjo, Yogyakarta, Indonesia.
Location
Kota yogyakarta,
Daerah istimewa yogyakarta
INDONESIA
Epidemiology and Society Health Review (ESHR)
Published by Universitas Ahmad Dahlan
ISSN : 26561107     EISSN : 26566052     DOI : https://doi.org/10.12928/eshr
Core Subject : Health,
Public Health
Epidemiology and Society Health Review (ESHR) is aims to communicate research in the field of epidemiology and community health by publishing papers in high-quality science. This journal publishes an article in the field of epidemiology of the communicable disease, epidemiology of non-communicable disease, epidemiology of nutrition, vector control, surveillance, and outbreak and spatial analysis for community health. ESHR opens the windows of the world to spread and communicate research as a lesson learns to other researchers and places to improve the quality of community health.
Arjuna Subject : Kedokteran - Epidemilogi
Articles 102 Documents
 7   8   9   10   11 
Correlation of Clinical and Immunological Factors With Overall Survival in Luminal B HER2-Negative Breast Cancer Patients at Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar Putra, I Komang Ery Purnama Warsana; Suryawisesa, IB. Made; Sudartana, Ketut
Epidemiology and Society Health Review (ESHR) Vol. 8 No. 1 (2026)
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26555/eshr.v8i1.14936

Abstract

Background: This study aimed to explore the relationship between clinico-pathological characteristics and overall survival (OS) among patients with Luminal B HER2-negative breast cancer treated at Prof. Dr. I.G.N.G Ngoerah Hospital, Denpasar. Method: A retrospective cohort study was conducted involving 248 patients diagnosed with Luminal B HER2-negative breast cancer between January 2018 and December 2022. Data were collected from medical records and the Bali Cancer Registry, including variables such as age, menopausal status, tumor size (T), nodal involvement (N), metastasis (M), lymphovascular invasion (LVI), tumor-infiltrating lymphocytes (TIL), and treatment modalities. OS was analyzed using the Kaplan–Meier method, and independent prognostic factors were identified through multivariate Cox proportional hazards regression. Results: Most patients were aged ≥40 years (84.8%), premenopausal (58.1%), and had LVI-positive tumors (65.9%). The 5-year OS rate was 60.8%, with a mean survival of 48 months. Kaplan–Meier analysis demonstrated shorter survival among older and postmenopausal patients. In multivariate analysis, TIL (HR = 0.342; 95% CI = 0.171–0.684; p < 0.001), age ≥40 years (HR = 1.459; 95% CI = 1.233–1.875; p < 0.001), and postmenopausal status (HR = 4.553; 95% CI = 2.378–8.733; p < 0.001) were identified as independent predictors of poorer survival. Conclusion: These findings underscore the prognostic importance of immunological and demographic factors in Luminal B HER2-negative breast cancer. The assessment of tumor-infiltrating lymphocytes may serve as a practical and feasible prognostic marker to support risk stratification and individualized management, particularly in resource-limited healthcare settings, while highlighting the need for strengthened early detection and follow-up strategies among older and postmenopausal women.
Health Equity in Dengue Prevention and Control: A Review of Social Vulnerability, Participation, and Climate-Related Risks Sulistyawati, Sulistyawati; Fatia Rizka Adela; Harini, Setiyo; Jatmika, Septian Emma Dwi
Epidemiology and Society Health Review (ESHR) Vol. 8 No. 1 (2026)
Publisher : Universitas Ahmad Dahlan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.26555/eshr.v8i1.15815

Abstract

Background: Dengue remains a major public health problem in tropical and subtropical regions, with transmission and disease outcomes strongly influenced by social, economic, and environmental conditions. Evidence indicates that inequities in socioeconomic status, community participation, healthcare access, and climate vulnerability contribute to unequal dengue burden, yet these aspects are rarely synthesized comprehensively. Methods: This narrative review was conducted following the PRISMA guidelines. A literature search was performed using Google Scholar to identify original research articles published between 2020 and 2025 that explicitly addressed equity-related aspects of dengue prevention and control. Data were analyzed using narrative synthesis. Results: Six studies from Asia, the Caribbean, and Latin America were included. The findings showed consistent inequities related to socioeconomic status, geographic access to healthcare, community participation, financial protection, and climate-related vulnerability. Low-income and marginalized populations experienced poorer preventive practices, higher out-of-pocket healthcare costs, and greater exposure to dengue risk, while unequal institutional capacity limited the implementation of climate-based early warning systems. Conclusion: Dengue prevention and control are shaped by multidimensional inequities operating across social, community, and health system levels. An equity-oriented approach is needed to strengthen dengue control strategies, particularly through inclusive community engagement, improved healthcare access, and climate-informed public health interventions.

Page 11 of 11 | Total Record : 102

 7   8   9   10   11 

Filter by Year

2019 2026


Reset
Filter By Issues
All Issue Vol. 8 No. 1 (2026) Vol. 7 No. 2 (2025) Vol. 7 No. 1 (2025) Vol. 6 No. 2 (2024) Vol. 6 No. 1 (2024) Vol. 5 No. 2 (2023) Vol. 5 No. 1 (2023) Vol. 4 No. 2 (2022) Vol 4, No 1 (2022) Vol. 4 No. 1 (2022) Vol 3, No 2 (2021) Vol. 3 No. 2 (2021) Vol 3, No 1 (2021) Vol. 3 No. 1 (2021) Vol 2, No 2 (2020) Vol. 2 No. 2 (2020) Vol. 2 No. 1 (2020) Vol 2, No 1 (2020) Vol 1, No 1 (2019) Vol. 1 No. 1 (2019) More Issue